Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026)
Sera Prognostics (SERA) reported Cash from Investing Activities of $9.0 million for Q1 2026, up 120.05% on a YoY basis from $4.1 million in Q1 2025, and up 52.55% quarter-over-quarter from $5.9 million in Q4 2025.
Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Cash from Investing Activities for 7 years, with the latest figure at $9.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 120.05% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $25.3 million (up 192.38% YoY), and the FY2025 full-year result was -$28.5 million, down 342.71% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $9.0 million, up from $5.9 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $14.6 million in Q1 2022, with the low at -$44.8 million in Q1 2025.
- Historically, Cash from Investing Activities has averaged -$105000.0 across 5 years, with a median of $4.9 million in 2024.
- The largest YoY upside for Cash from Investing Activities was 35792.68% in 2022 against a maximum downside of 1322.35% in 2022.
- Sera Prognostics' Cash from Investing Activities stood at -$1.6 million in 2022, then jumped by 123.7% to $374000.0 in 2023, then soared by 1874.6% to $7.4 million in 2024, then retreated by 20.24% to $5.9 million in 2025, then soared by 52.55% to $9.0 million in 2026.
- The last three Cash from Investing Activities figures came in at $9.0 million (Q1 2026), $5.9 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | 8.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.99 Mn |
| Mar 31, 2026 | 8.99 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Mar 31, 2025 | -44.80 Mn |
| Mar 31, 2025 | -44.80 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | -5.69 Mn |
| Mar 31, 2024 | -5.69 Mn |
| Dec 31, 2023 | 374,000.00 |
| Dec 31, 2023 | 374,000.00 |